Back to VRTX
Candriam S.C.A. VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
6
Latest value
$111.7M
Q3 2026
Peak value
$111.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $68.4M |
| Q4 2025 | $102.1M |
| Q4 2025 | $102.1M |
| Q1 2026 | $102.2M |
| Q2 2026 | $99M |
| Q3 2026 | $111.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $111.7M | 212.9K | — | — |
| Q2 2026 | $99M | 199.5K | — | — |
| Q1 2026 | $102.2M | 228.9K | — | — |
| Q4 2025 | $102.1M | 225.3K | — | — |
| Q4 2025 | $102.1M | 225.3K | — | — |
| Q3 2025 | $68.4M | 174.6K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B
$5.9B
$5.9B
$5.7B
$5.5B